Cambridge University Press Mental Health Books 2015

Me ntal H e a lth Books 2015

Welcome to the M enta l H e alth books catalogue 2015.

Here you will find new and forthcoming titles, representing the highest level of clinical practice from renowned authors.

The continuum leading from psychiatry, through clinical psychology, neuropsychology, neurology, and then through neuropsychiatry back to psychiatry again, provides a highly cohesive focus to the Cambridge list in mental health and the clinical brain sciences.

We have broad coverage across all the major specialties. There is a particular strength in psychopharmacology.

The major disorder-groups are well covered and there are significant clusters of titles in areas like the addictions, eating disorders, sleep disorders and trauma. The list is further supported by a strong selection of related journals.

Our publications are available in a variety of formats, including ebooks and print, as well as online collections for institutional purchase via our publishing service University Publishing Online, which incorporates the Cambridge Books Online platform.

To see more book listings, product information, extracts and reviews, you can find us online at www.cambridge.org/medicine You can also keep up to date with the latest news and author views by visiting our Cambridge Medicine blog at www.cambridgemedicine.wordpress.com We are always keen to expand our Mental Health publishing program and would be very pleased to talk to you about any new publishing possibilities – books, journals or digital products - in the field. You can find a list of useful contacts by going to www.cambridge.org/meditors We hope that you enjoy reading about our latest publications.

Richard Marley

Publishing Director, Medicine

Key Highlights 3 Stephen M. Stahl 4 Mental Health, Psychiatry and Clinical Psychology 7 Related Titles from Cambridge Psychology 14 Information on related journals On back cover

Order online now at www.cambridge.org/mentalhealth General enquiries: +44 (0)1223 326050 When purchasing, please quote the product ISBNs. For information about our privacy and data protection policy, please visit www.cambridge.org/privacy or email mlist@cambridge.org

Follow us on Twitter @cambUP_medicine

Sign up to Cambridge Alerts for regular updates and to receive 20% off your next online purchase

www.cambridge.org/alerts

Key Highlights A Concise Guide to Understanding Suicide Epidemiology, Pathophysiology and Prevention Edited by Stephen H. Koslow University of Miami

Pedro Ruiz University of Miami

and Charles B. Nemeroff University of Miami

Leading researchers summarize research on understanding, treating and preventing suicide and provide practical information for educating practising clinicians, health care workers and researchers and a pathway for undergraduate and graduate students interested in solutions to suicide.

It will also appeal to the University community and lay public nationally and internationally.

Contents: Introduction: looking to the future – how can research prevent suicide?; Part I. Understanding Suicide: 1. Brief history of suicide in Western cultures; 2. Global epidemiology of suicide; 3. Identification and screening of suicide risk; 4. Rethinking suicide risk assessment and risk formulation; 5. High risk cognitive states; 6. Suicide clusters and suicide contagion; 7. Ethnicity: how much of our understanding of suicide is applicable across ethnic cultures?; 8. Suicide-related bereavement and grief; 9. Statistics; Part II. Suicidal Comorbidities: 10. Current and chronic signs and symptoms; 11. Anxiety, depression and suicide: epidemiology, pathophysiology and prevention; 12. Suicide in schizophrenia; 13. Personality disorders and suicide; 14. Suicide and substance use disorders; 15. Eating disorders and suicide; 16. Suicidality and epilepsy: a complex relationship; Part III. Special Populations: 17. Suicidal ideation and behavior during pregnancy and the postpartum period; 18. Childhood and adolescence; 19. Indigenous/ native populations; 20. Bullying and suicidality in youth; 21. College students; 22. Suicide in older adults; 23. Armed forces; 24. Medical illness; 25. Suicide in the criminal justice system; Part IV. Treatment: 26. Reduction of suicidal behavior in bipolar disorder patients during long-term treatment with lithium; 27. Clozapine; 28. Antidepressants; 29. Suicide and emergency room treatment; 30. Psychosocial approaches to reduce suicidal behavior; Part V. Research: Mediators and Moderators: 31. Genome-wide association studies of suicidal behaviors; 32. Epigenetics; 33. The use of neuroimaging to investigate the pathophysiology of suicide; 34. Brain serotonin in suicides with psychological autopsy; 35. The noradrenergic system in depression and suicide; 36. Brain CRF and the HPA axis in suicide; 37. Receptor signaling in suicide; Part VI. Suicide Prevention: 38. Strategies to improve suicide prevention; 39. Safety planning to prevent suicidal behavior; 40. Contracting for safety; 41. Suicide and the media; Index.

2014 246 x 189 mm 408pp 28 b/w illus. 8 colour illus. 20 tables 978-1-107-03323-8 Hardback £75.00 / US$115.00 For all formats available, see

www.cambridge.org/9781107033238

Attention-Deficit Hyperactivity Disorder in Adults and Children Edited by Lenard A. Adler New York University School of Medicine

Thomas J. Spencer

3

School Mental Health Global Challenges and Opportunities Edited by Stan Kutcher Dalhousie University and the IWK Health Centre, Nova Scotia

Yifeng Wei

Harvard Medical School

IWK Health Centre and Dalhousie University, Nova Scotia

and Timothy E. Wilens

and Mark D. Weist

Massachusetts General Hospital

A comprehensive text, written by leading experts, detailing the significant advances in the treatment of ADHD in both children and adults. The wide ranging coverage includes the history, diagnosis, comorbidity, new psychopharmacologic medications and cognitive and behavioral therapy techniques for anyone involved in the assessment and management of ADHD. Contents: Preface; 1. Introduction; 2. History of Attention-Deficit/Hyperactivity Disorder (ADHD); 3. Diagnosing ADHD in children and Adults; 4. The epidemiology and societal burden of ADHD; 5. Functional impairment in ADHD; 6. Beyond DSM-IV diagnostic criteria: what changed and what should have changed in DSM-5; 7. Conceptual issues in understanding comorbidity in ADHD; 8. Bipolar disorder and ADHD: comorbidity throughout the lifecycle; 9. Assessment and treatment of depressive disorders in adults with ADHD; 10. Comorbidity of ADHD and anxiety disorders: diagnosis and treatment across the lifespan; 11. AttentionDeficit/Hyperactivity Disorder and the substance use disorders in ADHD; 12. ADHD and learning disorders; 13. Oppositional defiant disorder and conduct disorder; 14. Mimics of ADHD: medical and neurological conditions; 15. Catecholamine influences on prefrontal cortex circuits and function; 16. Molecular genetics of ADHD; 17. Neuroimaging of ADHD; 18. Neuropsychological testing; 19. ADHD diagnostic and symptom assessment scales for adults; 20. Assessment of ADHD in children and adolescents; 21. Stimulant medication in children and adolescents; 22. Non-stimulant treatment of ADHD; 23. Pharmacotherapy of ADHD in adults; 24. Psychosocial treatment of ADHD in adults; 25. Complementary and alternative treatments for pediatric and adult ADHD; 26. Preschool ADHD treatment; 27. ADHD and smoking; 28. ADHD and Tourette’s disorder; 29. Sustainable change: treatment adherence in ADHD; 30. College students with ADHD; Index.

2014 246 x 189 mm 368pp 14 b/w illus. 28 tables 978-0-521-11398-4 Hardback £75.00 / US$120.00 Publication November 2014 For all formats available, see

www.cambridge.org/9780521113984

University of South Carolina

This book provides vivid examples of school mental health innovations from eighteen countries, addressing mental health promotion, prevention and interventions. These initiatives and innovations enable readers from different regions and disciplines to apply strategies to help students achieve and maintain mental health, enhance their learning outcomes and access services, worldwide.

Contents: List of contributors; 1. The global advancement of school mental health for adolescents; 2. Developing and sustaining mental health and wellbeing in Australian schools; 3. The ‘Cool Mind’ program (‘Programa Cuca Legal’): mental health literacy for middle and high school teachers of the public system in Brazil; 4. A collaborative and sustainable approach to address mental health promotion and early identification in schools in the Canadian Province of Nova Scotia and beyond; 5. The future of teaching mental health literacy in schools; 6. School centred mental health: creating school connectedness that fosters the mental wellness of its community’s children, youth and families; 7. Components of mental health care in schools in China: an overview; 8. Mental health education for children and adolescents in China; 9. School mental health programs in India: current status and future directions; 10. School mental health: a perspective from Iraq; 11. Supporting a whole school approach to mental health promotion and wellbeing in post-primary schools in Ireland; 12. School mental health in Israel: background, services and challenges; 13. Development of a mental health literacy program for secondary school students in Japan; 14. A peer mental health educator model for African schools: untapped potential; 15. The current state of school mental health approaches and initiatives in Mexico and Chile; 16. Flourishing schools in Aotearoa, New Zealand: the wellbeing in schools model; 17. Universal schooling and mental health: towards school mental health in Northern Ghana; 18. A Singapore model – REACH; 19. Improving mental health via schools: a perspective from Istanbul, Turkey; 20. School and community mental health promotion strategies for youth in Ukraine; 21. Innovative contemplative/ mindfulness based approaches to mental health in schools; 22. The life course model for providing empirically supported school-based services for adolescents; 23. Interconnecting school mental health and school-wide positive behavior support; 24. Global school mental health: considerations and future directions; Index.

2015 234 x 156 mm 352pp 15 b/w illus. 16 tables 978-1-107-05390-8 Hardback £95.00 / US$150.00 Publication March 2015 For all formats available, see

www.cambridge.org/9781107053908

eBooks available at www.cambridge.org/ebookstore

4

Stephen M. Stahl

Key Highlights

Functional Remediation for Bipolar Disorder Eduard Vieta Universitat de Barcelona

Carla Torrent Hospital Clinic of Barcelona

and Anabel Martinez-Aran Hospital Clinic of Barcelona

Managing cognitive deficits in bipolar disorder presents a significant challenge. This manual describes the implementation of interventions aimed at improving the functional and social recovery of patients. A valuable resource for psychologists, psychiatrists, and other healthcare professionals caring for patients with bipolar disorder.

Contents: Preface; Acknowledgements; 1. Cognition and functioning in bipolar disorder; 2. Cognitive remediation in psychiatric disorders; 3. Functional remediation in bipolar patients; 4. Functional remediation programme: sessions and content; 5. Efficacy of the functional remediation programme; Appendices; References; Index.

2014 297 x 210 mm 144pp 42 b/w illus. 3 tables 978-1-107-66332-9 Paperback £35.00 / US$55.00 Publication November 2014 For all formats available, see

www.cambridge.org/9781107663329

H i gh l i gh t

Prescriber’s Guide

Stahl’s Essential Psychopharmacology Fifth edition Stephen M. Stahl University of California, San Diego

With coverage of 16 brand-new drugs – including six fresh-to-market critical new compounds – and incorporating the latest information on new indications, new formulations, new recommendations and new safety data, the fifth edition of this indispensable guide provides the essential practical support required by anyone prescribing in the field of mental health.

Review of previous edition: ‘This manual has all the characteristics of a true bestseller. The format is very attractive, the information is complete, the consultation is easy. In no other recent text will a clinician find so much information in such a concise and user-friendly format.’

Acta Psychiatrica Scandinavica Contents: 1. Acamprosate; 2. Agomelatine; 3. Alprazolam; 4. Amisulpride; 5. Amitriptyline; 6. Amoxapine; 7. Amphetamine (d); 8. Amphetamine (d,l); 9. Aripiprazole; 10. Armadafinil; 11. Asenapine; 12. Atomoxetine; 13. Benztropine; 14. Blonanserin; 15. Buprenorphine; 16. Bupropion; 17. Buspirone; 18. Caprylidene; 19. Carbamazepine; 20. Chlordiazepoxide; 21. Chlorpromazine; 22. Citalopram; 23. Clomipramine; 24. Clonazepam; 25. Clonidine; 26. Clorazepate; 27. Clozapine; 28. Cyamemazine; 29. Desipramine; 30. Desvenlafaxine; 31. Dextromethorphan; 32. Diazepam; 33. Diphenhydramine; 34. Disulfiram; 35. Donepezil; 36. Dothiepin; 37. Doxepin; 38. Duloxetine; 39. Escitalopram; 40. Estazolam; 41. Eszopiclone; 42. Flumazenil; 43. Flunitrazepam; 44. Fluoxetine; 45. Fluphenthixol; 46. Fluphenazine; 47. Flurazepam; 48. Fluvoxamine; 49. Gabapentin; 50. Galantamine; 51. Guanfacine; 52. Haloperidol; 53. Hydroxyzine; 54. I-methylfolate; 55. Iloperidone; 56. Imipramine; 57. Isocarboxazid; 58. Ketamine; 59. Lamotrigine; 60. Levetiracetam; 61. Levomilnacipran; 62. Lisdexamfetamine; 63. Lithium; 64. Lorcaserin; 65. Lofepramine; 66. Loflazeptate; 67. Lorazepam; 68. Loxapine; 69. Lurasidone; 70. Mainserin; 71. Maprotiline; 72. Memantine; 73. Mesoridazine; 74. Methylphenidate (d); 75. Midazolam; 76. Milnacipran; 77. Mirtazapine; 78. Moclobemide; 79. Modafinil; 80. Molindone; 81. Nalmefene; 82. Naltrexone; 83. Nefazodone; 84. Nortriptyline; 85. Olanzapine; 86. Oxazepam; 87. Oxcarbazepine; 88. Paliperidone; 89. Paroxetine; 90. Perospirone; 91. Perphenazine; 92. Phenelzine; 93. Phenterminetopiramate; 94. Pimozide; 95. Pipothiazine; 96. Prazosin; 97. Pregabalin; 98. Propranolol; 99. Protriptyline; 100. Quazepam; 101. Quetiapine; 102. Ramelteon; 103. Reboxetine; 104. Risperidone; 105. Rivastigmine; 106. Selegiline; 107. Sertindole; 108. Sertraline; 109. Sodium

Oxybate; 110. Sulpiride; 111. Temazepam; 112. Thioridazine; 113. Thiothixene; 114. Tiagabine; 115. Tianeptine; 116. Trihexyphenidyl; 117. Triiodothyronine; 118. Topiramate; 119. Tranylcypromide; 120. Trazodone; 121. Triazolam; 122. Trifluoperazine; 123. Trimipramine; 124. Valproate; 125. Varenicline; 126. Venlafaxine; 127. Vortioxetine; 128. Zalepron; 129. Ziprasidone; 130. Zolpidem; 131. Zonisamide; 132. Zopiclone; 133. Zotepine; 134. Zuclopenthixol.

2014 228 x 138 mm 824pp 2 b/w illus.

978-1-107-67502-5 Paperback £58.00 / US$90.00 For all formats available, see

www.cambridge.org/9781107675025

Stahl’s Essential Psychopharmacology Neuroscientific Basis and Practical Applications Fourth edition Stephen M. Stahl University of California, San Diego

This fully revised edition returns to the essential roots of what it means to become a neurobiologically empowered psychopharmacologist, expertly guided in the selection of treatments for individual patients. This remains the essential text for all students and professionals in mental health seeking to understand and utilize current therapeutics.

Review of previous edition: ‘… essential reading … I would thoroughly recommend this book to anyone who works with psychotropic drugs – or who has the task of teaching others about them!’

American Journal of Psychiatry Contents: Preface to the fourth edition; CME information; 1. Chemical neurotransmission; 2. Transporters, receptors and enzymes as targets of psychopharmacological drug action; 3. Ion channels as targets of psychopharmacological drug action; 4. Psychosis and schizophrenia; 5. Antipsychotic agents; 6. Mood disorders; 7. Antidepressants; 8. Mood stabilizers; 9. Anxiety disorders and anxiolytics; 10. Chronic pain and its treatment; 11. Disorders of sleep and wakefulness and their treatment; 12. Attention deficit hyperactivity disorder and its treatment; 13. Dementia and its treatment; 14. Impulsivity, compulsivity and addiction; Suggested reading and selected references; Index.

2013 246 x 189 mm 628pp 588 colour illus. 57 tables 978-1-107-02598-1 Hardback £124.99 / US$199.99 978-1-107-68646-5 Paperback £69.99 / US$99.99 For all formats available, see

www.cambridge.org/9781107025981

Stephen M. Stahl

H i gh l i gh t

Stahl’s Essential Psychopharmacology Neuroscientific Basis and Practical Applications Fourth edition Stephen Stahl University of California, San Diego

This is a product combining the fourth edition of Dr Stahl’s market-leading psychopharmacology textbook with a one-year subscription to www. stahlonline.org providing access to the full range of other Stahl content.

Contents: Preface to the fourth edition; CME information; 1. Chemical neurotransmission; 2. Transporters, receptors and enzymes as targets of psychopharmacological drug action; 3. Ion channels as targets of psychopharmacological drug action; 4. Psychosis and schizophrenia; 5. Antipsychotic agents; 6. Mood disorders; 7. Antidepressants; 8. Mood stabilizers; 9. Anxiety disorders and anxiolytics; 10. Chronic pain and its treatment; 11. Disorders of sleep and wakefulness and their treatment; 12. Attention deficit hyperactivity disorder and its treatment; 13. Dementia and its treatment; 14. Impulsivity, compulsivity and addiction; Suggested reading and selected references; Index.

2014 246 x 189 mm 620pp 978-1-107-58767-0 Print and Online Bundle £190.00 / US$294.00 For all formats available, see

www.cambridge.org/9781107587670

Stahl’s Illustrated Antidepressants Stephen M. Stahl University of California, San Diego

All of the titles in the Stahl’s Illustrated Series are designed to be fun. Concepts are illustrated by full-color images that will be familiar to all readers of Stahl’s Essential Psychopharmacology, Third Edition and The Prescriber’s Guide. The visual learner will find that these books make psychopharmacology concepts easy to master, while the non-visual learner will enjoy a shortened text version of complex psychopharmacology concepts.

Contents: 1. Neurobiology of depression; 2. Selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs); 3. Norepinephrine and dopamine reuptake inhibitors (NDRIs) and selective norepinephrine reuptake inhibitors (NRIs); 4. Alpha 2 antagonists as serotonin and norepinephrine; 5. Monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs); 6. Building a treatment plan with novel treatment and augmentation options for depression; 7. Depression in women: treating symptoms throughout the life span; 8. Pharmacokinetics and algorithms to treat depression.

Stahl’s Illustrated

2009 152 x 110 mm 200pp 219 colour illus. 9 tables 978-0-521-75852-9 Paperback £34.99 / US$54.99 For all formats available, see

Stahl’s Illustrated Violence

Neural Circuits, Genetics and Treatment Stephen M. Stahl University of California, San Diego

Assisted by Debbi Ann Morrissette Neuroscience Education Institute

This pocket-sized volume in the Stahl’s Illustrated series combines theoretical information from Stahl’s Essential Psychopharmacology with practical data from The Prescriber’s Guide. This highlyillustrated guide presents the underlying neurobiology, genetic predisposition and management of aggressive behaviours in patients with psychiatric disorders.

Contents: Preface; CME information; Objectives; Introduction; 1. Which individuals will become violent or aggressive?; 2. Neurobiology and genetics of violence and aggression; 3. Treatment of violence and aggression; Summary; References; Index; CME: posttest and certificate.

www.cambridge.org/9780521758529

Stahl’s Illustrated Antipsychotics

Treating Psychosis, Mania and Depression Second edition Stephen M. Stahl University of California, San Diego

and Laurence Mignon

Titles in the Stahl’s Illustrated series are designed to be fun. Concepts are illustrated by full-color images that will be familiar to all readers of Stahl’s Essential Psychopharmacology, Third Edition and The Prescriber’s Guide. The visual learner will find that these books make psychopharmacology concepts easy to master, while the non-visual learner will enjoy a shortened text version of complex psychopharmacology concepts.

2014 210 x 146 mm 120pp 978-1-107-44160-6 Paperback £31.99 / US$50.00

Contents: 1. Neurobiology of schizophrenia and mood disorders; 2. Multifunctionality of antipsychotics; 3. Side effects of antipsychotics: metabolic issues and sedation; 4. Individual antipsychotic drugs; 5. Schizophrenia pharmacy and switching strategies.

For all formats available, see

Stahl’s Illustrated

Stahl’s Illustrated

www.cambridge.org/9781107441606

2010 208 x 148 mm 200pp 178 colour illus. 7 tables 978-0-521-14905-1 Paperback £34.99 / US$54.99 For all formats available, see

www.cambridge.org/9780521149051

5

Stahl’s Illustrated Anxiety, Stress, and PTSD Stephen M. Stahl University of California, San Diego

and Meghan M. Grady Illustrated by Nancy Muntner

The Stahl’s Illustrated books are a series of pocket-sized, mid-priced, themed volumes. They distil theoretical information from the Stahl’s Essential Psychopharmacology volume and combine this with practical data from The Prescriber’s Guide. The visual learner will find that these books make the concepts easier to master, and the non-visual learner will appreciate the clear, shortened text on complex psychopharmacological concepts.

Contents: 1. Neurobiology of stress and anxiety; 2. Post-traumatic stress disorder (PTSD); 3. Neurotransmitter systems as pharmacological targets for PTSD; 4. First-line medications for PTSD; 5. Second-line, adjunct, and investigational medications for PTSD; 6. Cognitive behavioral therapy (CBT) for PTSD; 7. Caring for patients with PTSD; 8. Unique considerations for the military population; Summary.

Stahl’s Illustrated

2010 208 x 148 mm 200pp 143 colour illus. 11 tables 27 exercises 978-0-521-15399-7 Paperback £34.99 / US$54.99 For all formats available, see

www.cambridge.org/9780521153997

Stahl’s Illustrated Attention Deficit Hyperactivity Disorder Stephen M. Stahl University of California, San Diego

and Laurence Mignon

As with Stahl’s Essential Psychopharmacology and The Prescriber’s Guide, Attention Deficit Hyperactivity Disorder is a colourful, user-friendly title. Visual learners will find these books make psychopharmacology concepts easy to master, while non-visual learners will enjoy shortened text versions of complex psychopharmacology models.

The content includes assessment and management of both child and adult ADHD. Contents: 1. Neurobiology, circuits, genetics; 2. ADHD across the ages; 3. Comorbidities of ADHD; 4. Drugs and mechanism of actions.

Stahl’s Illustrated

2009 210 x 149 mm 166pp 100 colour illus. 9 tables 978-0-521-13315-9 Paperback £34.99 / US$54.99 For all formats available, see

www.cambridge.org/9780521133159

For regular email alerts visit www.cambridge.org/alerts

6

Stephen M. Stahl

Stahl’s Illustrated Chronic Pain and Fibromyalgia

Stahl’s Illustrated Substance Use and Impulsive Disorders

Stephen M. Stahl

Stephen M. Stahl

University of California, San Diego

University of California, San Diego

Illustrated by Nancy Muntner Edited by Sara Ball

and Meghan M. Grady

Chronic Pain and Fibromyalgia is a colourful, user-friendly title in Stahl’s series. Visual learners will find these books make concepts in psychopharmologic and nonpsychopharmologic pain medications easy to master, while non-visual learners will enjoy shortened text versions of complex models. The title is essential reading for pharmaceutical professionals, neurologists and pain management specialists.

The pocket-sized, themed volumes in the Stahl’s Illustrated series combine theoretical information from Stahl’s Essential Psychopharmacology with practical data from The Prescriber’s Guide. Visual learners will find that these books make the concepts easier to master, and non-visual learners will appreciate the clear, shortened text on complex psychopharmacological concepts.

Contents: 1. Pain affects us all; 2. Neurobiology of pain; 3. The ‘pain patient’; 4. Pain disorders; 5. Pain drugs; 6. Monitoring and caring for patients in pain.

Stahl’s Illustrated

2009 210 x 149 mm 176pp 144 colour illus. 7 tables 978-0-521-13322-7 Paperback £31.99 / US$50.00 For all formats available, see

www.cambridge.org/9780521133227

Neuroscience Education Institute

Contents: Preface; CME information; Objectives; 1. Substance use and addiction: an overview; 2. The neurobiology of reward and drug addiction; 3. Alcohol; 4. Opioids; 5. Nicotine; 6. Stimulants; 7. Marijuana; 8. Other drugs of abuse; 9. Psychosocial treatment for substance use disorders; 10. Disorders of impulsivity and compulsivity; Summary; Abbreviations; References; Index; CME: posttest and certificate.

Stahl’s Illustrated

2012 210 x 149 mm 183pp 100 colour illus. 13 tables 978-1-107-67453-0 Paperback £34.99 / US$54.99

Stahl’s Illustrated Mood Stabilizers

For all formats available, see

Stephen M. Stahl

Best Practices in Medical Teaching

University of California, San Diego

All of the titles in the Stahl’s Illustrated series are designed to be fun. Concepts are illustrated by full-color images that will be familiar to all readers of Stahl’s Essential Psychopharmacology, Third Edition and The Prescriber’s Guide. The visual learner will find that these books make psychopharmacology concepts easy to master, while the non-visual learner will enjoy a shortened text version of complex psychopharmacology concepts.

Contents: 1. Symptoms and spectrum of bipolar disorder; 2. From symptoms to circuits; 3. From circuits to mechanisms; 4. Lithium and various anticonvulsants as mood stabilizers for bipolar disorder; 5. Atypical antipsychotics as mood stabilizers for bipolar disorder; 6. Building a treatment plan.

Stahl’s Illustrated

2009 210 x 149 mm 176pp 150 colour illus. 10 tables 978-0-521-75849-9 Paperback £34.99 / US$54.99 For all formats available, see

www.cambridge.org/9780521758499

www.cambridge.org/9781107674530

Stephen M. Stahl University of California, San Diego

and Richard L. Davis Arbor Scientia

Best Practices in Medical Teaching explains and illustrates the general principles of effective medical presentation. Stahl and Davis are leading experts in medical communication and they effectively explain the practice and methods behind their success.

‘This marvellous gem of a book is truly unique. Practical, easy to understand and apply … the authors, true practitioners of their craft, have been considered among the best for years.’

Javaid I. Sheikh, MD, MBA, Acting Dean, Professor of Psychiatry, Weill Cornell Medical College Contents: Foreword; Preface; Introduction; 1. Applying the principles of adult education to the designing of medical presentations; 2. Using audience learning psychology to advantage in designing and delivering medical presentations;

3. Executing the principles of adult learning in medical presentations; 4. Measuring outcomes and ensuring success; 5. Using interval learning in a comprehensive medical educational program; References; Index.

2011 234 x 156 mm 192pp 98 b/w illus. 35 tables 978-0-521-15176-4 Paperback £34.99 / US$59.99 For all formats available, see

www.cambridge.org/9780521151764

Case Studies: Stahl’s Essential Psychopharmacology Stephen M. Stahl University of California, San Diego

Edited by Debbi A. Morrissette Illustrated by Nancy Muntner

Capitalizing on Dr Stahl’s greatest strength – the ability to address complex issues in an understandable way and with direct relevance to the everyday experience of clinicians – this book is about living through the treatments that work, the treatments that fail, and the mistakes made along the journey.

‘The case studies accurately reflect the complicated nature of the patients that we encounter in our practices … This novel book helps us look inside the mind of a seasoned psychopharmacologist and how he bridges the gap between research and clinical practice.’

Doody’s Notes Contents: 1. The man whose antidepressants stopped working; 2. The son who would not take a shower; 3. The man who kept hitting his wife over the head with a frying pan; 4. The son who could not go to bed; 5. The sleepy woman with anxiety; 6. The woman who felt numb; 7. The case of physician do not heal thyself; 8. The son whose parents were desperate to have him avoid Kraepelin; 9. The soldier who thinks he is a ‘slacker’ broken beyond all repair after 3 deployments to Iraq; 10. The young man everybody was afraid to treat; 11. The young woman whose doctors could not decide whether she has schizophrenia, bipolar disorder or both; 12. The scary man with only partial symptom control on clozapine; 13. The 8-year-old girl who was naughty; 14. The scatter-brained mother whose daughter has ADHD, like mother, like daughter; 15. The doctor who couldn’t keep up with his patients; 16. The computer analyst who thought the government would choke him to death; 17. The severely depressed man with a life insurance policy soon to lose its suicide exemption; 18. The anxious woman who was more afraid of her anxiety medications than of anything else; 19. The psychotic woman with delusions that no medication could fix; 20. The breast cancer survivor who couldn’t remember how to cook; 21. The woman who has always been out of control; 22. The young man with depression and alcohol abuse – like father, like son, like grandfather, like father, like great grandfather, like grandfather; 23. The woman with psychotic depression responsive to her own TMS machine; 24. The boy getting kicked out of his classroom; 25. The young man whose

Mental Health, Psychiatry and Clinical Psychology dyskinesia was prompt and not tardive; 26. The patient whose daughter wouldn’t give up; 27. The psychotic arsonist who burned his house and tried to burn himself; 28. The woman with depression whose Parkinson’s Disease vanished; 29. The depressed man who thought he was out of options; 30. The woman who was either manic or fat; 31. The girl who couldn’t find a doctor; 32. The man who wondered if once a bipolar always a bipolar?; 33. Suck it up, soldier, and quit whining; 34. The young man who is failing to launch; 35. The young cancer survivor with panic; 36. The man whose antipsychotic almost killed him; 37. The painful man who soaked up his opiates like a sponge; 38. The woman with an ever fluctuating mood; 39. The psychotic sex offender with grandiosity and mania; 40. The elderly man with schizophrenia and Alzheimer’s Disease; Index.

2011 228 x 140 mm 500pp 978-0-521-18208-9 Paperback £49.99 / US$79.99 For all formats available, see

www.cambridge.org/9780521182089

Stahl’s Self-Assessment Examination in Psychiatry Multiple Choice Questions for Clinicians Stephen M. Stahl University of California, San Diego

150 questions derived from the Neuroscience Education Institute’s Master Psychopharmacology Program help the reader prepare for formal tests, including American Board of Psychiatry and Neurology examinations, and achieve CME and MoC credits towards ABPN re-accreditation. The selfassessment questions also offer detailed explanations of correct and incorrect answers.

Contents: 1. Basic neuroscience; 2. Unipolar depression; 3. Bipolar disorder; 4. Psychosis; 5. Anxiety; 6. ADHD; 7. Dementia; 8. Pain; 9. Sleep; 10. SUD; Index.

2012 186 x 123 mm 336pp 978-1-107-68159-0 Paperback £39.99 / US$54.99 For all formats available, see

www.cambridge.org/9781107681590

The Burdens of Mental Disorders

Global Perspectives from the WHO World Mental Health Surveys Edited by Jordi Alonso

Behavioral Neurology & Neuropsychiatry Edited by David B. Arciniegas University of Colorado, School of Medicine

C. Alan Anderson

Universitat Pompeu Fabra, Barcelona

University of Colorado, School of Medicine

Somnath Chatterji

and Christopher M. Filley

World Health Organization, Geneva

University of Colorado, School of Medicine

and Yanling He

This is the only textbook designed specifically for trainees and practitioners in behavioral neurology and neuropsychiatry, a developing medical subspecialty. The principles of clinical neuroanatomy, neuropsychiatric assessment and treatment described by internationally renowned contributors prepare clinicians for work with patients affected by neuropsychiatric and neurological conditions.

Shanghai Mental Health Center, Shanghai

This volume uses the findings of the WHO Mental Health surveys, which included more than 120,000 people from 24 countries, to present a comprehensive portrait of the burden of mental disorders. Considering both the individual and societal costs, this volume is valuable for anyone involved in mental health policy making.

Contents: Acknowledgements; Part I. Introduction: 1. Burdens of mental disorders: the approach of the World Mental Health (WMH) surveys; 2. Methods of the World Mental Health surveys; Part II. Mental Disorders and Personal Disadvantages: 3. Parent psychopathology and offspring mental disorders; 4. Associations between mental disorders and early termination of education; 5. Mental disorders, marriage and divorce; 6. Premarital mental disorders and risk for marital violence; 7. Early-onset mental disorders and their links to chronic physical conditions in adulthood; Part III. Mental Disorders and Productivity Losses: 8. Association between serious mental illness and personal earnings; 9. Early-onset mental disorders and adult household income; 10. Family burden associated with mental and physical disorders; Part IV. Disability and Perceived Health Associated with Common Mental and Physical Disorders: 11. Days totally out of role associated with common mental and physical disorders; 12. Partial disability associated with common mental and physical disorders; 13. Disorder-specific disability and treatment of common mental and physical disorders; 14. Disability associated with common mental and physical disorders; 15. Perceived health associated with common mental and physical disorders; 16. Decomposing the total associations of common mental and physical disorders with perceived health; Part V. Implications and Future Directions: 17. The burden of mental disorders in the Global Burden of Disease 2010 study and the World Mental Health surveys: similarities, differences and implications for mental health research; 18. The burdens of mental disorders: implications for policy; 19. Conclusions and future directions; Appendices; Index.

2013 246 x 189 mm 332pp 17 b/w illus. 107 tables 978-1-107-01928-7 Hardback £79.99 / US$124.99 For all formats available, see

www.cambridge.org/9781107019287

7

‘This superb book is the most complete and comprehensive publication on this subject to date. It is essential reading for all who call themselves behavioral neurologists or neuropsychiatrists.

It is also an essential reference for the care of patients who suffer from neuropsychiatric disorders.’

Doody’s Reviews Contents: Preface; Foreword; 1. Introduction; Part I. Structural and Functional Neuroanatomy: 2. Behavioral neuroanatomy: brainstem, subcortical structures, limbic system, and cerebral cortex and supporting structures; 3. Cerebellum; 4. White matter; 5. Frontal-subcortical circuits; 6. Arousal; 7. Sleep; 8. Attention; 9. Motivation; 10. Perception and recognition; 11. Memory; 12. Language; 13. Prosody; 14. Praxis; 15. Visuospatial function; 16. Executive function; 17. Comportment; 18. Emotion; 19. Personality; Part II. Neurobehavioral and Neuropsychiatric Assessment: 20. Neuropsychiatric evaluation; 21. Neurological examination; 22. Assessment for subtle neurological signs; 23. Mental status examination; 24. Neuropsychological assessment; 25. Forensic assessment; 26. Structural neuroimaging; 27. Advanced neuroimaging; 28. Electroencephalography; 29. Advanced electrophysiology; 30. Neurotoxicology; 31. Neuropathological assessment; Part III. Treatments in Behavioral Neurology and Neuropsychiatry: 32. Principles of pharmacotherapy; 33. Rehabilitation and pharmacotherapy of cognitive impairment; 34. Pharmacotherapy of emotional disturbances; 35. Pharmacotherapy of behavioral disturbances; 36. Psychotherapy; 37. Environmental and behavioral interventions; 38. Procedural interventions; Index.

2013 246 x 189 mm 681pp 127 b/w illus. 43 colour illus.

978-0-521-87501-1 Hardback £94.99 / US$144.99 For all formats available, see

www.cambridge.org/9780521875011

Visit our website at www.cambridge.org/knowledge

8

Mental Health, Psychiatry and Clinical Psychology

The Maudsley Reader in Phenomenological Psychiatry Edited by Matthew R. Broome University of Warwick

Robert Harland South London and Maudsley NHS Foundation Trust

Gareth S. Owen Institute of Psychiatry, London

and Argyris Stringaris Institute of Psychiatry, London

This unique book brings together and interprets previously hard-to-find texts, new translations and passages detailing the interplay between philosophy and psychopathology, making them accessible to a new generation of mental health researchers, practitioners and policy makers. ‘[The Reader] brings together texts from both philosophers and clinicians which are otherwise difficult to access; many are newly translated … I found it absorbing and illuminating.’

Baroness Mary Warnock, House of Lords Contents: Prologue; How to read this book; Acknowledgements; Part I. Intellectual Background: 1. Introduction; Section 1. Influences on Phenomenology: 2. Franz Brentano (1838–1917): Brentano, F. (1887), ‘The Concept of a Descriptive Psychology’; Brentano, F. (1874), ‘The Distinction between Mental and Physical Phenomena’; 3. Wilhelm Dilthey (1833–1911): Dilthey, W. (1894), ‘Ideas about a Descriptive and Analytical Psychology’; 4. Max Weber (1864–1920): Weber, M. (1949), ‘Objectivity’ in Social Science and Social Policy’; 5. Henri Bergson (1859–1941): Bergson, H. (1910), Selections from ‘Time and Free Will: An Essay on the Immediate Data of Consciousness’; Section 2. Phenomenological Philosophy: 6. Edmund Husserl (1859–1938): Husserl, E. (1919), ‘Ideas 1’; Husserl, E. (1948), Selections from ‘Experience and Judgment’; 7. Max Scheler (1874–1928): Scheler, M. (1913–14) ‘Phenomenology and the Theory of Cognition’; Scheler, M. (1928), Selections from ‘Man’s Place in Nature’; Scheler, M. (1913–16), ‘Feeling and Feeling States’; Scheler, M. (1922), Selections from ‘The Nature of Sympathy’; Scheler, M. (1914), ‘On the Idea of Man’; Scheler, M. (1928), Selections from ‘The Human Place in the Cosmos’; 8. Martin Heidegger (1889–1976): Heidegger, M. (1919), ‘The Idea of Philosophy and the Problem of Worldview,’ War Emergency Semester; Heidegger, M. (1994), Selections from ‘Introduction to Phenomenological Research’; Heidegger, M. (1927), ‘The Worldhood of the World’; Heidegger, M. (1927), ‘Fear as a Mode of State-of-Mind’; Part II. The Phenomenological Approach in Psychiatry: 9. Introduction; 10. Jaspers’ approach 1: static understanding – ‘phenomenology’: Jaspers, K. (1912), ‘The Phenomenological Approach in Psychopathology’; 11. Jaspers’ approach 2: genetic understanding – ‘Verstehen’: Jaspers, K. (1959), ‘Meaningful psychic connections’; 12. Minkowski’s structural approach: Minkowski, E. (1933), ‘The Notion of a Generating Disorder and the Structural Analysis of Mental Disorders’; 13. Binswanger’s

existential approach: Binswanger, L. (1946), ‘The Existential Analysis School of Thought’; Part III. Phenomenologies of Mental Disorder: 14. Introduction; 15. Brain injury: Goldstein, K. (1940), ‘Pathology and the Nature of Man: The Abstract Attitude in Patients with Lesions of the Brain Cortex’; 16. Schizophrenia: Jaspers, K. (1959), ‘The Worlds of Schizophrenic Patients’; Minkowski, E. (1927), ‘The Essential Disorder Underlying Schizophrenia and Schizophrenic Thought’; Binswanger, L. (1956), ‘Extravagance, Perverseness, Manneristic Behaviour and Schizophrenia’; Blankenburg, W. (1968), ‘First Steps Toward a Psychopathology of ‘Common Sense’’; Blankenburg, W. (1965), ‘On the Differential Phenomenology of Delusional Perception: A Study of an Abnormal Significant Experience’; Conrad, K. (1958), ‘Beginning Schizophrenia: Attempt for a Gestalt-Analysis of Delusion’; Rümke, H. (1948), ‘The Nuclear Symptom of Schizophrenia and the Praecox Feeling’; 17. Affective disorder: Binswanger, L. (1964), ‘On the Manic Mode of Being-in-theWorld’; Schneider, K. (1920), ‘The Stratification of Emotional Life and the Structure of States of Depression’; Straus, E. (1928), ‘The Experience of Time in Endogenous Depression and in the Psychopathic Depressive State’; von Gebstattel, V. (1928), ‘Compulsive Thought Relating to Time in Melancholia’; Tellenbach, H. (1982), ‘Melancholy as Endocosmogenic Psychosis’; 18. Obsessive compulsive disorder: Straus, E. (1938), ‘The Pathology of Compulsion’; von Gebsattel, V. (1938), ‘The World of the Compulsive’; 19. Other: Scheler, M. (1913), ‘The Psychology of So-called Compensation Hysteria and the Real Battle against Illness’; von Gebsattel, V. (1963), ‘The Meaning of Medical Practice’; Merleau-Ponty, M. (1945), ‘Cézanne’s Doubt’; Epilogue; Index.

2013 246 x 189 mm 295pp 978-0-521-88275-0 Hardback £84.99 / US$134.99 978-0-521-70927-9 Paperback £44.99 / US$69.99

Contents: Foreword; Preface; Part I. Pharmacology of Cannabis and the Endocannabinoid System: 1. The cannabinoid system from the point of view of a chemist; 2. The function of the endocannabinoid system; 3. How cannabis works in the brain; Part II. The Changing Face of Cannabis: 4. The epidemiology of cannabis use: an international perspective; 5. Is cannabis becoming more potent?; 6. Health policy and cannabis; Part III. Cannabis and the Brain: 7. Cannabis, endocannabinoids and neurodevelopment; 8. The impact of pubertal exposure to cannabis on the brain: a focus on animal studies; 9. Cannabis and cognition: short and long-term effects; 10. Does cannabis cause lasting brain damage?; Part IV. Cannabis, Anxiety and Mood: 11. Acute and subacute psychiatric effects of cannabis; 12. The association between cannabis use and depression; 13. Cannabis and bipolar disorder; Part V. Cannabis and Psychosis: 14. Cannabis and psychosis proneness; 15. Genetic factors that moderate the psychomimetic effects of cannabis; 16. Cannabis causes positive, negative, cognitive symptoms and produces impairments in electrophysiological indices of information processing; 17. The neural basis for the acute effects of cannabis on learning and psychosis; Part VI. Cannabinoids and Schizophrenia: Aetiopathology and Treatment Implications: 18. Does cannabis cause schizophrenia?; 19. Postmortem studies of the brain cannabinoid system in schizophrenia; 20. The endogenous cannabinoid system in schizophrenia; 21. The endocannabinoid system as a target for pharmacotherapy of schizophrenia; Part VII. Cannabis and its Impact on Schizophrenia: 22. Acute effects of cannabis in established schizophrenia; 23. Cannabis and the long-term course of schizophrenia; 24. Motives that maintain cannabis use in schizophrenia; 25. Treatment interventions for cannabis abuse in people with psychosis; Part VIII. Integration: 26. Cannabis and mental illness: an integration; Index.

www.cambridge.org/9780521882750

2011 246 x 189 mm 252pp 29 b/w illus. 8 tables 978-1-107-00021-6 Hardback £64.99 / US$99.99

Marijuana and Madness

For all formats available, see

For all formats available, see

Second edition Edited by David Castle University of Melbourne

Robin M. Murray Institute of Psychiatry

and Deepak Cyril D’Souza Yale University, Connecticut

The second edition of this critically acclaimed and award-winning text provides a comprehensive overview of the psychiatry and neuroscience of cannabis. It has been extensively updated and expanded with 10 new chapters to incorporate major new research findings. It is suitable for all members of the mental health team.

‘The editors and publishers of this book have responded to a need for clear, research-based information on a topic of great current concern. They have done an excellent job.’

American Journal of Psychiatry

www.cambridge.org/9781107000216

Emergency Psychiatry Arjun Chanmugam Johns Hopkins Medical Institutions

Patrick Triplett Johns Hopkins Medical Institutions

and Gabor Kelen The Johns Hopkins University

Providers in primary care, emergency care or other acute care environments encounter patients with psychiatric problems. These presentations can be difficult to manage and often pose significant challenges for both the provider and the patient. This book reviews the most common psychiatric disorders and provides succinct management recommendations.

Contents: Preface; 1. General approach; 2. Management of agitation and violence; 3. Suicide assessments; 4. Managing substance abuse; 5. The psychotic patient; 6. The delirious patient; 7. The anxious patient;

Mental Health, Psychiatry and Clinical Psychology

8. Mood disorders; 9. Personality disorders; 10. Geriatric psychiatry; 11. Medicolegal and risk management; 12. Pediatric psychiatry; 13. Emergency department evaluation of intellectual and developmental disabilities; 14. Eating disorders; 15. Chronic pain; 16. Death, dying and grief; 17. Pregnancy and women’s issues; 18. Multicultural issues and safety.

2013 234 x 156 mm 318pp 978-0-521-87926-2 Hardback £69.99 / US$104.99 For all formats available, see

www.cambridge.org/9780521879262

Medically Unexplained Symptoms, Somatisation and Bodily Distress Developing Better Clinical Services Edited by Francis Creed University of Manchester

Peter Henningsen

pharmacologically related) drugs, giving valuable information to the wide range of healthcare professionals who prescribe and monitor these extensively utilised therapeutic agents.

Contents: Preface; Part I. Setting the Scene: 1. The origins of psychopharma; 2. Some preliminaries; Part II. The Syndromes: 3. Acute dystonias; 4. Parkinsonism; 5. Akathisia; 6. Tardive dyskinesia; Part III. Particular Issues: 7. Tardive and chronic dystonia; 8. Special populations; Part IV. Assessment: 9. The clinical examination; 10. An overview of some standardised recording instruments; Part V. Matters Arising: 11. Involuntary movements and schizophrenia: a limitation to the concept of tardive dyskinesia?; 12. And finally … the salutary tale of ‘atypicality’; References; Index.

2014 246 x 189 mm 383pp 70 b/w illus. 72 tables 978-1-107-02286-7 Hardback £75.00 / US$120.00 For all formats available, see

www.cambridge.org/9781107022867

Technische Universität München

and Per Fink Aarhus Universitet, Denmark

Medically unexplained symptoms are the fifth most common reason for visits to doctors in the USA, and form one of the most expensive diagnostic categories in Europe. This authoritative text defines international best practice. An important resource for psychiatrists, clinical psychologists, primary care doctors and those responsible for health policy.

Contents: 1. Epidemiology: prevalence, causes and consequences; 2. Terminology, classification and concepts; 3. Evidence-based treatment; 4. Current state of management and organisation of care; 5. Barriers to improving treatment; 6. Gender, lifespan and cultural aspects; 7. Medically unexplained symptoms in children and adolescents; 8. Identification, assessment and treatment of individual patients; 9. Training; 10. Achieving optimal treatment organisation in different countries – suggestions for service development applicable across different healthcare systems; Index.

2011 234 x 156 mm 266pp 20 b/w illus. 29 tables 978-0-521-76223-6 Hardback £64.99 / US$104.99 For all formats available, see

www.cambridge.org/9780521762236

A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs Second edition D. G. Cunningham Owens University of Edinburgh

Provides a comprehensive, literaturebased but clinically oriented overview of the pervasive neurological adverse effects that frequently affect those receiving antipsychotic (and

Health Inequalities and People with Intellectual Disabilities Eric Emerson University of Sydney and Lancaster University

and Chris Hatton Lancaster University

People with intellectual disabilities die younger and have poorer health than their peers. This book provides an authoritative, evidence-based overview of why this happens and what needs to be done. It is an invaluable resource for practitioners, advocates, policymakers and researchers concerned with the health and wellbeing of disabled people.

‘There is no comparable book on the market. The authors are to be commended for tackling such a difficult subject.’

Doody’s Reviews Contents: Preface; 1. People with intellectual disabilities; 2. Health and health inequalities; 3. The health of people with intellectual disabilities; 4. Applying a health inequalities perspective; 5. Addressing the health inequalities faced by people with intellectual disabilities; 6. Conclusions; References; Index.

2013 234 x 156 mm 173pp 15 b/w illus. 5 tables 978-0-521-13314-2 Paperback £35.00 / US$56.00 For all formats available, see

www.cambridge.org/9780521133142

9

Neurologic Differential Diagnosis A Case-Based Approach

Edited by Alan B. Ettinger Albert Einstein College of Medicine, New York

and Deborah M. Weisbrot State University of New York, Stony Brook

Using a case study approach, each chapter is dedicated to a specific presenting symptom or sign and includes the associated key features, quickly reminding the clinician which investigations are needed in the doctorpatient encounter. An invaluable text for neurologists and psychiatrists at all stages of training.

Contents: Foreword; Preface; Part I. Differential Diagnosis of Abnormal Symptoms and Signs: 1. Introduction: localization and differential diagnosis in neurology; 2. Agitation and aggressive behavior in patients with dementia or developmental disability; 3. Agnosias; 4. Anxiety and panic; 5. Aphasia; 6. Apraxia; 7. Ataxia: subacute or chronic; 8. Ataxia, acute, or subacute; 9. Attentional problems; 10. Autonomic failure or syndromes; 11. Bulbar, pseudobulbar; 12. Catatonic-like states; 13. Chorea; 14. Coma; 15. Dementia; 16. Depression and suicidal ideation; 17. Diplopia; 18. Dissociative disorder; 19. Dizziness; 20. Drop attacks; 21. Dysarthria; 22. Dysphagia; 23. Dystonia; 24. Eating disorders; 25. Eye movements, abnormal; 26. Falls; 27. Foot drop; 28. Gait abnormalities; 29. Hallucinations, visual; 30. Headache; 31. Hearing deficit; 32. Hypersomnolence; 33. Incontinence; 34. Mania and bipolar symptoms; 35. Medically unexplained symptoms; 36. Memory loss and cognitive decline, acute and subacute, amnesia; 37. Mental status change, acute [and delirium]; 38. Movement disorders in psychiatric disorders; 39. Movement abnormalities in the face; 40. Movements, focal, clonic; 41. Movements, complex motor activity; 42. Movements during sleep; 43. Movements, tonic-clonic type; 44. Mutism; 45. Myalgia, cramps; 46. Myoclonus; 47. Myotonia; 48. Nystagmus; 49. Ophthalmoparesis, gaze conjugate lateral deficit and conjugate vertical deficit; 50. Pain, eye; 51. Pain, neck; 52. Pain, arm; 53. Pain, back; 54. Pain, face; 55. Papilledema; 56. Paresthesias; 57. Parkinson’s Disease and related extrapyramidal syndromes; 58. Proptosis [exophthalmos]; 59. Psychosis, thought disorder; 60. Ptosis; 61. Pupil constriction and Horner’s syndrome; 62. Pupil dilatation; 63. Respiratory difficulties, neurologic causes; 64. Retardation, mental; 65. Seizure; 66. Sensory deficits and abnormal sensations; 67. Sensory deficits in the face; 68. Smell deficit; 69. Spasm, hemifacial; 70. Stroke and hemorrhage syndromes; 71. Stroke in adults, etiologies; 72. Stroke in the young, etiologies; 73. Syncope; 74. Tinnitus; 75. Tremor; 76. Vertigo; 77. Visual loss, acute bilateral; 78. Visual loss, monocular; 79. Visual field deficits; 80. Weakness, generalized acute; 81. Weakness, hemiparesis; 82. Weakness, proximal; 83. Weakness, monomelic; 84. Weakness, neck; 85. Weakness, paraparesis; 86. Weakness in ICU; Part II. Differential Diagnosis within Specific Localizations: 87. Cavernous sinus syndrome; 88. Facial nerve palsy; 89. Fourth nerve palsy; 90. Myelopathy;

eBooks available at www.cambridge.org/ebookstore

10

Mental Health, Psychiatry and Clinical Psychology

91. Nerve, cranial: multiple deficit; 92. Neuropathy, tibial; 93. Neuropathy, femoral; 94. Neuropathy, radial; 95. Neuropathy, sciatic; 96. Neuropathy, axonal versus demyelinating; 97. Neuropathy, median and carpal tunnel; 98. Neuropathy, ulnar; 99. Plexopathy, brachial; 100. Plexopathy, lumbar; 101. Radiculopathy; 102. Sixth nerve palsy; 103. Third nerve palsy; Index.

Cognitive Behaviour Therapy for Children and Families

2014 246 x 189 mm 689pp 111 b/w illus. 175 tables 978-1-107-01455-8 Hardback £65.00 / US$99.00

University of Reading

For all formats available, see

www.cambridge.org/9781107014558

Medical Writing A Prescription for Clarity

Fourth edition Neville W. Goodman Southmead Hospital, Bristol

and Martin B. Edwards Edited by Elise Langdon-Neuner Illustrated by Andy Black University of Bristol

Whether you are writing a simple clinical report or thesis, supervising others, or just want to develop your skills in effective written communication, this book is the ideal guide and reference.

This new and expanded edition of this invaluable handbook retains the clear, simple and precise style popular with readers.

Review of previous edition: ‘Read this book, and make sure your students do …’

British Journal of Psychiatry Contents: Foreword; Preface; Part I. Problem: The Illness: 1. Introduction; 2. The malaise of medical manuscripts; 3. The difficulties of English as an additional language (EAL); Part II. Solution: Symptomatic Relief: 4. Technology, changing language, and authority; 5. Guidelines to clearer writing; 6. Spelling; 7. Is there a better word?; 8. Superfluous words; 9. Imprecise words; 10. Superfluous phrases; 11. Trouble with short words; 12. Use of the passive voice; 13. Consistency: number and tenses; 14. Word order; 15. Punctuation; 16. Circumlocution; 17. Words and parts of speech for EAL writers; 18. Clichés and article titles; 19. Constructing sentences; 20. Further help with sentences for EAL writers; 21. Drawing clear graphs; 22. It can be done; Part III. Practice: Recuperation: 23. Exercises; Appendix: British-American English; References and further reading; Index.

2014 234 x 156 mm 380pp 24 b/w illus. 4 tables 978-1-107-62815-1 Paperback £37.50 / US$60.00 For all formats available, see

www.cambridge.org/9781107628151

Third edition Edited by Philip Graham Institute of Child Health

and Shirley Reynolds

This is the third edition of a comprehensive, authoritative text covering the cognitive behaviour therapy interventions for all conditions seen in children and adolescents. The international panel of contributors ensures the highly authoritative and relevant nature of the content, making this text an invaluable source for all child and adolescent mental health professionals.

Review of previous edition: ‘I really do like the balance of theory, evidence for theory and practice, practice tips and worked examples showing how to apply the treatment in real life … I highly recommend this book, to any student, be they new to the field or experienced practitioners of child and adolescent mental health who want a grasp of contemporary CBT in CAMHS.’ Psychological Medicine Contents: Preface; 1. Introduction; Part I. Developmental Cognitive Theory and Clinical Practice: 2. Anxiety and depression in young people: developmental considerations; 3. Adapting cognitive and behavioural therapy for children and adolescents; 4. Issues in evaluation of psychotherapies; Part II. Engagement and Assessment: 5. Engagement; 6. Formulation: a systematic approach in cognitive behaviour therapy; Part III. Client Groups: 7. Working collaboratively with parents and carers in cognitive behaviour therapy; 8. Working with black and ethnic minority children and their families; 9. Working with schools and children’s wider social environment; Part IV. Cognitive Approaches to Children Facing Adversity: 10. Trauma-focused cognitive behavioural therapy for child sexual abuse; 11. Children with chronic and life-limiting health problems; 12. Cognitive approaches to children with chronic pain; Part V. Applications in Specific Child and Adolescent Syndromes: 13. Cognitive behavioural therapies for youth with autistic spectrum disorders; 14. Eating disorders; 15. Treating broad-based anxiety problems in children; 16. Post-traumatic stress disorders; 17. Phobic anxiety; 18. Obsessive compulsive disorder; 19. Depressive disorders; Part VI. CBT Applications in Preventive Interventions: 20. Prevention of conduct disorders: cognitive behavioural approaches; 21. Prevention of anxiety disorders; Part VII. New Developments in CBT for Children: 22. Using low intensity treatment methods with families; 23. Using

new technologies to deliver cognitive behaviour therapy with children and adolescents; 24. Mindfulness interventions in child and adolescent psychopathology; 25. Conclusions and future directions; Index.

Cambridge Child and Adolescent Psychiatry

2013 247 x 174 mm 411pp 30 b/w illus. 9 tables 978-1-107-68985-5 Paperback £54.99 / US$89.99 For all formats available, see

www.cambridge.org/9781107689855

Cognitive Impairment in Schizophrenia

Characteristics, Assessment and Treatment Edited by Philip D. Harvey University of Miami

This book presents state-of-the-art understanding of the most important features of severe mental illness: cognition and disability. Written in an accessible, informative style by leading experts, this is essential reading for researchers and clinicians working with patients impaired by severe mental illness.

Contents: Preface; Part I. Characteristics of Cognitive Impairment in Schizophrenia: 1. Cognition in schizophrenia as a central illness feature; 2. The multi-faceted, ‘global’ cognitive impairment profile in schizophrenia; 3. Comparative impairments across schizophrenia and bipolar disorder; 4. Cognitive impairment and symptom dimensions in psychosis; Part II. Functional Implications and Course: 5. Neurocognition and functional outcome in schizophrenia: filling in the gaps; 6. Cognition and work functioning in schizophrenia; 7. Cognition and functional status in adult and older patients with schizophrenia; 8. Social cognition and its relationship to neurocognition; 9. Cognitive functioning and awareness of illness in schizophrenia: a review and meta-analysis; Part III. Genetic and Biological Contributions to Cognitive Impairment: 10. Genetic influences on cognition in schizophrenia; 11. Neurobiological determinants of cognition; 12. Translational cognitive neuroscience of schizophrenia: bridging neurocognitive and computational approaches towards understanding cognitive defects; Part IV. Assessment and Treatment of Cognitive Impairment and Related Features: 13. Assessment of cognition in schizophrenia treatment; 14. Performancebased measures of functioning in schizophrenia; 15. Pharmacological approaches to cognitive enhancement; 16. Computerized cognitive training in schizophrenia: current knowledge and future directions; Index.

2013 234 x 156 mm 328pp 34 b/w illus. 7 colour illus.

978-1-107-01320-9 Hardback £59.99 / US$99.99 For all formats available, see

www.cambridge.org/9781107013209

Mental Health, Psychiatry and Clinical Psychology

Brain Stimulation in Psychiatry

ECT, DBS, TMS and Other Modalities Charles H. Kellner Mount Sinai School of Medicine, New York

The field of brain stimulation is advancing at rapid pace with a growing number of techniques now approved for the treatment of psychiatric illness.

This text acts both as a concise, quick reference for experienced practitioners and a guidebook for residents learning about clinical brain stimulation techniques. ‘… this pocket-sized book is up to date, practical, and user friendly and is highly recommended as an easy reference guide for anyone practising psychiatry or neurology.’

Journal of Clinical Psychiatry Contents: 1. Introduction; 2. Electroconvulsive therapy (ECT): basic concepts; 3. Electroconvulsive therapy (ECT): patient selection and preparation; 4. Electroconvulsive therapy (ECT): technique; 5. Electroconvulsive therapy (ECT): treatment course; 6. Electroconvulsive therapy (ECT): common adverse effects; 7. Electroconvulsive therapy (ECT): the ECT service; 8. Electroconvulsive therapy (ECT): special issues; 9. Deep brain stimulation (DBS); 10. Transcranial magnetic stimulation (rTMS); 11. Magnetic seizure therapy (MST); 12. Vagus nerve stimulation (VNS); 13. Transcranial direct current stimulation (TDCS); Index.

2012 234 x 156 mm 158pp 16 b/w illus.

978-0-521-17255-4 Paperback £39.99 / US$64.99 For all formats available, see

www.cambridge.org/9780521172554

Clinical Handbook for the Management of Mood Disorders Edited by J. John Mann Columbia University, New York

Edited in association with Patrick J. McGrath Columbia University, New York

and Steven P. Roose Columbia University, New York

This book equips clinicians with the knowledge to refine their diagnostic skills and implement treatment plans based on the most up-to-date evidence on interventions that work. Covering the widest range of treatments and techniques, this book provides clear guidance for the management of all types and subtypes of minor and major depression.

‘This is the most comprehensive book on mood disorders available, and it is written by top experts in the field.

Whether treating a newly diagnosed patient with depression or a patient

with treatment-resistant depression, this is the source to have right at your fingertips.’

Doody’s Review Service Contents: Preface; Part I. Introduction: 1. Models of depression; 2. Diagnosis of mood disorders; 3. Dysthymia and chronic depression; Part II. Medical Management: 4. Management of adult major depressive disorder; 5. Atypical depression; 6. Psychotic depression; 7. Pharmacologic and somatic treatments for bipolar depression; 8. Medication treatment of mania: acute and preventive; 9. Treatment of mood disorders in later life; 10. Chronic depression; 11. Pediatric depression; 12. Therapeutics of pediatric bipolar disorder; 13. Depression in the context of physical illness; 14. Mood disorders in the context of borderline personality disorder; 15. Depression in the context of pregnancy; 16. Depression and the menstrual cycle; 17. Depression in the context of alcoholism and other substance use disorders; 18. Complementary and alternative treatments for mood disorders; Part III. Psychotherapies for Mood Disorders: 19. Cognitive behavior therapy; 20. Interpersonal therapy; 21. Dialectical behavioral therapy for mood disorders; 22. The psychodynamic treatment of mood disorders; 23. Combining medication and psychotherapy in the treatment of depression; Part IV. Specific Modalities of Treatment: 24. Electroconvulsive therapy; 25. Transcranial magnetic stimulation and deep brain stimulation; 26. Chronotherapeutics: light therapy, wake therapy, and melatonin; 27. Ketamine in treatment-resistant depression; Part V. The Promise of Biomarkers and Response Prediction: 28. Brain imaging; 29. Pharmacogenetics and mood disorders; 30. Electrophysiological predictors of clinical response to antidepressants; Part VI. Future Directions: 31. Future directions; Index.

behavior based on a large and representative sample … It is unique in its extensive, comprehensive, and detailed tables of data …’

Doody’s Notes Contents: Acknowledgements; Part I. Introduction: 1. Global perspectives on suicidal behavior; 2. The epidemiology of suicide and suicidal behavior; 3. Methods of the World Mental Health Surveys; Part II. Prevalence and Course of Suicidal Behavior: 4. Prevalence, onset, and transitions among suicidal behaviors; 5. Persistence of suicidal behaviors over time; Part III. Lifetime Risk Factors for Suicidal Behavior: 6. Sociodemographic risk factors for suicidal behavior: results from the WHO World Mental Health Surveys; 7. Parental psychopathology and the risk of suicidal behavior; 8. Childhood adversities as risk factors for onset and persistence of suicidal behavior; 9. Traumatic events and suicidal behavior; 10. Mental disorders and comorbidity: results from the WHO World Mental Health Surveys; 11. Chronic physical conditions and the onset of suicidal behavior; 12. Integrative models of suicidal behavior; Part IV. 12-Month Risk Factors and Treatment: 13. Prevalence and identification of groups at risk for 12-month suicidal behavior in the WHO World Mental Health Surveys; 14. Treatment of suicidal persons around the world; Part V. Conclusions and Future Directions: 15. Research, clinical, and policy implications of the World Mental Health Surveys findings on suicidal behavior; 16. Conclusions and future directions; Index.

2012 254 x 178 mm 401pp 17 b/w illus. 3 colour illus. 50 tables 978-0-521-76500-8 Hardback £84.99 / US$129.99 For all formats available, see

www.cambridge.org/9780521765008

2013 246 x 189 mm 426pp 26 b/w illus. 20 tables 978-1-107-02463-2 Hardback £69.99 / US$104.99

Principles of Psychiatric Genetics

For all formats available, see

Edited by John I. Nurnberger, Jr

www.cambridge.org/9781107024632

11

Indiana University School of Medicine

and Wade Berrettini

Suicide

Global Perspectives from the WHO World Mental Health Surveys Matthew K. Nock Harvard University, Massachusetts

Guilherme Borges National Institute of Psychiatry, Mexico

and Yutaka Ono Keio University, Tokyo

Suicide is a serious public health problem worldwide, accounting for more deaths annually than all forms of war and interpersonal violence combined.

This book presents the results of the largest, most representative study of suicidal behaviors conducted to date, providing valuable information for anyone seeking to understand suicidal behavior.

University of Pennsylvania School of Medicine

Psychiatric genetics is a rapidly advancing field, elucidating the varied roles of specific genes in brain development and dysregulation.

This up-to-date compilation features 22 disorder-based chapters, with additional focus on key topics including epidemiology and ethics. An indispensable reference for psychiatrists, neurologists, psychologists and anyone involved in psychiatric genetic studies.

‘A magnificent and timely contribution.

I especially enjoyed Dan Geschwind’s chapter on autism.’

Solomon Snyder, University Distinguished Service Professor of Neuroscience, Pharmacology and Psychiatry, The Johns Hopkins University School of Medicine

‘The book represents an unprecedented opportunity to understand and prevent suicidal

Visit our website at www.cambridge.org/knowledge

12

Mental Health, Psychiatry and Clinical Psychology

Contents: Preface; 1. Contribution of genetic epidemiology to our understanding of psychiatric disorders; 2. A basic overview of contemporary human genetic analysis strategies; 3. In silico analysis strategies and resources for psychiatric genetics research; 4. Gene expression studies in psychiatric disorders; 5. Pharmacogenetics in psychiatry; 6. Functional validation of candidate genetic susceptibility factors for major mental illnesses: from protein chemistry, cell biology, animal study, to human brain imaging; 7. Epigenetic mechanisms in drug addiction and depression; 8. Panic disorder; 9. The genetics of phobic disorders and generalized anxiety disorder; 10. Genetic contributions to obsessivecompulsive disorder (OCD) and OCD-related disorders; 11. Post-traumatic stress disorder; 12. Antisocial behavior: gene environment interplay; 13. Learning disabilities; 14. Autism and autism spectrum disorders; 15. Genetics of major depression; 16. The genetics of anorexia and bulimia nervosa; 17. Genetics and common human obesity; 18. Alcoholism; 19. Nicotine dependence; 20. Genetics of stimulant dependence; 21. Genetics of personality disorders; 22. Ethical issues in behavioral genetics; 23. Genetics of Tourette syndrome and related disorders; 24. Endophenotypes; 25. Developmental disorders; Index.

2012 246 x 189 mm 432pp 58 b/w illus. 21 colour illus.

978-0-521-89649-8 Hardback £94.99 / US$154.99 For all formats available, see

www.cambridge.org/9780521896498

Essentials of Global Mental Health Edited by Samuel O. Okpaku Center for Health, Culture, and Society, Nashville

Defines an approach to mental healthcare focused on the provision of evidence-based, cost-effective treatments, founded on the principles of sharing the best information about common problems and achieving international equity in coverage, options and outcomes.

Contents: Preface; Introduction; Part I. History and Background to Global Mental Health: 1. History of global mental health; 2. Burden of illness; 3. Trends and gaps in mental health disparities; 4. Global health and mental health as diplomacy; 5. Global mental health and the United Nations; Part II. Advocacy and Reduction of Stigma: 6. Voice of user survivor; 7. Lecture on internalized stigma; 8. Definition and process of stigma; 9. Stigmatization and exclusion; 10. Grassroots mental health movements; 11. The rise of consumerism and local advocacy; 12. Programs to reduce stigma in HIV/AIDS, mental illness and epilepsy; Part III. Systems of Development: 13. The challenges of human resources in low and middle income countries; 14. Integration of mental health services in primary care settings; 15. Collaboration between traditional and Western practitioners; 16. Setting up an integrated mental health system; Part IV. Systems of Development for Special Populations: 17. Poverty and perinatal morbidity as risk factors for mental illness; 18. Maternal mental health care: refining the components in a South African setting; 19. Screening for developmental disabilities in epidemiologic studies in low and middle income

countries; 20. Child services; 21. Child abuse as a global mental health problem; 22. Child soldiers; 23. Mental health and intellectual disability: implications for global mental health; 24. Adolescent alcohol and substance abuse; 25. Developing intervention in low resource contexts; Part V. Gender and Equality: 26. Strategies to reduce women’s mental illness and increase attention to women’s mental health; 27. Violence against women; 28. Women and global mental health: vulnerability and empowerment; 29. Trafficking in persons; Part VI. Human Resources and Capacity Building: 30. Capacity building; 31. Use of allied professionals; 32. Mental health and illness in conflict areas; 33. Implications of disasters for global mental health; 34. International response to natural and manmade disasters; 35. Global health governance and international law, and mental health; 36. The role of NGOs; 37. Mental health, mass communication and media; Part VII. Suicide and Violence: 38. Suicide and depression; 39. Violence as a public health problem; 40. Setting up integrated mental health systems: the case of Cuba; 41. The war on drugs – the US, Mexico and Central American countries and Plan Colombia and Merida; Part VIII. Research and Monitoring Progress of Countries: 42. Medical education and global mental health; 43. Research priorities for mental health in low and middle income countries (LMIC); 44. Research infrastructure; 45. Monitoring progress of countries; Epilogue; Index.

2014 246 x 189 mm 465pp 26 b/w illus. 37 tables 978-1-107-02232-4 Hardback £85.00 / US$135.00 For all formats available, see

www.cambridge.org/9781107022324

Clinical Psychology for Trainees

Foundations of Science-Informed Practice Second edition Andrew Page University of Western Australia, Perth

and Werner Stritzke University of Western Australia, Perth

Fully updated for DSM-5, with three new chapters, this revised edition covers practical clinical skills with a focus on the scientist-practitioner model. It provides clinical psychology trainees with a practical template for making use of evidence-based science in interviewing, diagnosis, assessment, treatment and case management.

Review of previous edition: ‘The authors argue convincingly that clinical psychologists working under modern cost-cutting and risk-averse conditions must demonstrate the efficiency and safety of their work scientifically if they are to survive in the workplace. Those considering, or just embarking on clinical training would do well to read this book, to develop a sense of ‘science’ as an ally and not a foe.’

Caroline Plumb, Journal of Psychosomatic Research

Contents: Preface; 1. A science-informed model of clinical psychology practice; 2. Relating with clients; 3. Assessing clients; 4. Monitoring client progress; 5. Linking assessment to treatment: case formulation; 6. Treating clients; 7. Brief interventions; 8. Group treatment; 9. Program evaluation; 10. Case management; 11. Supervision; 12. Managing ruptures in therapeutic alliance; 13. Respecting the humanity of clients: cross-cultural and ethical aspects of practice; 14. Working in rural and remote settings; 15. Psychologists as health care providers; Index.

2014 234 x 156 mm 280pp 71 b/w illus. 7 tables 978-1-107-61398-0 Paperback £45.00 / US$70.00 Publication November 2014 For all formats available, see

www.cambridge.org/9781107613980

Cerebral Small Vessel Disease Edited by Leonardo Pantoni Azienda Ospedaliero Universitaria Careggi

and Philip B. Gorelick College of Human Medicine, Michigan State University

Written by leading international experts in the field, Cerebral Small Vessel Disease provides up-to-date information about the causes, diagnosis, treatment and prevention of this important condition. The rapid development of neuroimaging techniques as screening and treatment tools is discussed.

Essential reading for neurologists, stroke physicians, geriatricians, and interventional neuroradiologists.

Contents: Preface; Part I. Classification, Pathology and Basic Aspects: 1. Definition and classification of small vessel diseases; 2. Pathology of cerebral small vessel disease; 3. Pathological aspects of the ischemic consequences of small vessel disease on brain parenchyma; 4. Pathological aspects of the hemorrhagic consequences of small vessel diseases on the brain; 5. Experimental animal models of cerebral small vessel disease; 6. Sporadic small vessels disease: pathogenic aspects; 7. Pathogenic aspects of hereditary small vessel disease of the brain; 8. Hereditary cerebral small vessel disease and role of genetic factors; 9. The link between large artery aging and cerebral small vessel disease; 10. The neurovascular unit and possible influences on cerebral small vessel disease; Part II. Neuroimaging and Laboratory Aspects: 11. Conventional brain imaging of white matter lesions; 12. Conventional imaging of lacunar infarcts; 13. Imaging of hemorrhagic cerebral small vessel disease; 14. Nonconventional MR techniques for imaging cerebral small vessel disease; 15. Cerebral hemodynamics in cerebral small vessel disease; 16. Markers of endothelial dysfunction, oxidative stress and inflammation in cerebral small vessels disease; 17. Cerebral small vessel disease: cerebrospinal fluid aspects; Part III. Clinical Aspects of Cerebral Small Vessel Disease: 18. Acute stroke syndromes caused by small vessel disease; 19. Cognitive consequences of cerebral small vessel disease; 20. Motor, stance and balance consequences of cerebral small vessel diseases; 21. Psychiatric

Mental Health, Psychiatry and Clinical Psychology

consequences of small vessel diseases; 22. Consequences of cerebral small vessel disease: disability, mortality and prognosis; 23. Clinical aspects of genetic forms of small vessel disease; 24. Interaction between cerebral small vessel disease and neurodegenerative changes; Part IV. Therapeutic Aspects: Prevention, Future Directions, and Possibilities: 25. Risk factors as possible targets for prevention of small vessel disease; 26. Treatment approaches for lacunar strokes; 27. Cerebral small vessels disease imaging as a surrogate marker for clinical trials; 28. Cerebral small vessel disease: a look to the future; Index.

schizophrenia: epidemiological and clinical aspects; 4. Obsessive-compulsive symptoms in schizophrenia: psychopathological characteristics; 5. Obsessive-compulsive symptoms in schizophrenia: prodrome; 6. Obsessive-compulsive symptoms in schizophrenia: across life span; 7. OCD-spectrum disorders in schizophrenia; 8. Schizotypal OCD; 9. OCD with poor insight; 10. Neurobiology of schizo-obsessive disorder; 11. Treatment of schizophrenia with obsessive-compulsive symptoms; 12. Antipsychotic druginduced obsessive-compulsive symptoms; 13. Conclusions and future directions; Index.

2014 246 x 189 mm 371pp 63 b/w illus. 55 colour illus. 26 tables 978-1-107-03166-1 Hardback £85.00 / US$135.00

2013 234 x 156 mm 245pp 11 b/w illus. 40 tables 978-1-107-00012-4 Hardback £69.99 / US$104.99

For all formats available, see

For all formats available, see

www.cambridge.org/9781107031661

www.cambridge.org/9781107000124

Mental Health and Poverty

The Autism Spectrum

Rob Poole

Scientific Foundations and Treatment Edited by Mark Reber

Bangor University

Drexel University, Philadelphia

Robert Higgo

Written for the wide range of physicians and professionals who treat children and adults with autism spectrum disorders, this book reviews the scientific research on the nature and causes of autism, outlines best treatment practices with children and describes a comprehensive assessment and treatment approach for adults.

Bangor University

and Catherine A. Robinson Bangor University

Poverty is not inevitable, even in a difficult economic climate, and there is strong scientific evidence that poverty is a cause of mental illness. This book brings together a body of knowledge from biomedical and social science literature, providing an evidence-based resource for mental health professionals, social scientists and their students.

Contents: Preface; 1. Severe mental illness and social factors; 2. Poverty; 3. Constellations of disadvantage; 4. Depression and anxiety; 5. Genetics; 6. Substance misuse; 7. Mechanisms; 8. Stigma; 9. Recovery; 10. Working with poverty; 11. Afterword; References; Index.

2013 234 x 156 mm 192pp 978-0-521-14396-7 Hardback £55.00 / US$85.00 For all formats available, see

www.cambridge.org/9780521143967

Schizo-Obsessive Disorder Michael Poyurovsky Tirat Carmel Mental Health Center, Israel

This is the first book to address the clinical and neurobiological interface between schizophrenia and obsessivecompulsive disorder (OCD). It uses numerous case studies to present diagnostic guidelines and to describe a recommended treatment algorithm, demystifying this complex disorder and aiding its effective management.

Contents: Foreword; Preface; 1. Schizophrenia and OCD: comparative characteristics; 2. Obsessive-compulsive symptoms in schizophrenia: conceptual history; 3. Obsessive-compulsive symptoms in

Contents: Part I. What We Know about Autism and How We Know It: 1. Nosology: definitions and diagnoses; 2. Epidemiology; 3. Phenomenology: the neuropsychology of autism; 4. Pathophysiology: the neuroscience of autism; 5. Etiology: syndromic autism; 6. Etiology: essential autism; Part II. Assessing and Treating Children with Autism: 7. Clinical diagnostic evaluation; 8. Special education; 9. Habilitation therapies (including speechlanguage and occupational therapies and assistive technology); 10. Behavioral therapies; 11. Pharmacotherapy and nutritional therapies; Part III. Assessing and Treating Adults with Autism: 12. Clinical assessment of adults; 13. Treatment planning for adults.

2012 234 x 156 mm 346pp 978-0-521-11687-9 Hardback £59.99 / US$94.99 For all formats available, see

www.cambridge.org/9780521116879

Common Epilepsy Pitfalls Case-Based Learning Dieter Schmidt Epilepsy Research Group, Free University of Berlin

13

can often trip clinicians. Common Epilepsy Pitfalls is a comprehensive guide to anticipating and managing the pitfalls in the diagnosis and management of epilepsy.

Contents: Preface; Introduction; 1. Mistaking non-epileptic events for epilepsy; 2. Mistaking EEG changes for epilepsy; 3. Radiographic errors in epilepsy; 4. The first seizure: is it epilepsy?; 5. When to start treatment?; 6. Which drug is best?; 7. How to optimize treatment?; 8. What to do if drugs don’t work?; 9. When to stop treatment; 10. Women with epilepsy; 11. Management of psychiatric issues in epilepsy; 12. Management of emergencies in epilepsy; 13. Management of social issues; Index.

2015 234 x 156 mm 224pp 50 b/w illus. 20 tables 978-0-521-27971-0 Paperback c. £45.00 / c. US$70.00 Publication June 2015 For all formats available, see

www.cambridge.org/9780521279710

Sleep and its Disorders in Children and Adolescents with a Neurodevelopmental Disorder A Review and Clinical Guide Gregory Stores University of Oxford

Based on a review of the literature and modern principles regarding childhood sleep disorders, this book provides paediatricians, paediatric neurologists, specialists in intellectual disability, psychiatrists, psychologists, and primary care staff with practical guidance for the investigation and management of sleep disturbance in children and adolescents with neurodevelopmental disorders.

Contents: Introductory remarks; 1. General outline of sleep and its disorders in children and adolescents; 2. Special considerations regarding sleep disturbance in children with a neurodevelopmental disorder; 3. Comorbid conditions in neurodevelopmental disorders capable of contributing to sleep disturbance; 4. Sleep disturbance in specific neurodevelopmental disorders; Envoi; Selected abbreviations of technical terms used in the sleep disorders field; Index.

2014 234 x 156 mm 176pp 1 b/w illus. 6 tables 978-1-107-40220-1 Paperback £45.00 / US$70.00 For all formats available, see

www.cambridge.org/9781107402201

and Steven Schachter Department of Neurology, Beth Israel Deaconess Medical Center, Boston

Epilepsy is amongst the most frequently encountered of neurological disorders, yet issues surrounding differential diagnosis, underlying causes, seizures, EEGs, treatment options and prognoses

For regular email alerts visit www.cambridge.org/alerts

14

Related Titles from Cambridge Psychology

Mental Health, Psychiatry and Clinical Psychology

Trauma and Forgiveness Consequences and Communities C. Fred Alford University of Maryland, College Park

C. Fred Alford argues that the traumatized are generally capable of representing their experience. Using evidence from the testimonies of Holocaust survivors, as well as the victims of ‘ordinary’ trauma, he shows that forgiveness is generally a way of avoiding the hurt and pain of coming to terms with trauma.

‘This book is a gem – a profound, eloquent, and memorable meditation on the ravages of trauma and the vicissitudes of forgiveness.’

Marshall Alcorn, The George Washington University Contents: 1. Introduction: trauma and forgiveness; 2. Is the Holocaust traumatic?; 3. Winnicott and trauma; 4. Melanie Klein and forgiveness: theory; 5. Melanie Klein and forgiveness: practice; 6. Winnicott: forgiveness and transitional experience; 7. Jean Améry: resentment, loneliness, and aging; 8. Conclusion: trauma as knowledge.

2014 228 x 152 mm 225pp 978-1-107-04340-4 Hardback £60.00 / US$95.00 For all formats available, see

www.cambridge.org/9781107043404

Melancholia The Western Malady Matthew Bell King’s College London

A unique explanation of melancholia, charting its fascinating history and demonstrating how it flourished because of the West’s peculiar fascination with self-consciousness. This book will appeal to readers interested in the cultural history of the West, as well as those with an interest in mental illness.

‘Matthew Bell’s knowledge of Western historical and cultural traditions is farreaching, deep, and employed to great advantage in this compelling book.

His account of the place of melancholy within these traditions, and its links to self-consciousness, are original and provocative, making Melancholia: The Western Malady a worthy successor and complement to earlier writing such as Jackson’s great Melancholia and Depression.’

Jennifer H. Radden, Professor Emerita, University of Massachusetts, Boston Contents: Introduction; 1. Naming a disease; 2. What’s wrong with me?; 3. Melancholy men, depressed women?; 4. The Western malady; 5. The telescope of truth; Conclusion.

2014 228 x 152 mm 224pp 1 b/w illus.

978-1-107-06996-1 Hardback £65.00 / US$99.00 For all formats available, see

www.cambridge.org/9781107069961

Cultural and Contextual Perspectives on Developmental Risk and Well-Being Edited by Jacob A. Burack McGill University, Montréal

and Louis A. Schmidt McMaster University, Ontario

The contributors to this volume provide insight into developmental well-being by examining the ways that culture and context affect outcomes associated with various types of risk, such as those related to oppression, academic performance, family background, life histories, physical health, and psychiatric conditions.

Contents: Series editor’s preface; 1. Introductory remarks: cultural and contextual perspectives on developmental risk and well-being; Part I. Cultural Perspectives on Developmental Risk and Well-Being: 2. Using multicultural research to expand the scope of developmental psychopathology; 3. Cultural perspectives on shyness-inhibition; 4. A sociocultural analysis of high-risk Native American children in schools; 5. Developmental perspectives on the role of cultural identity in well-being: evidence from aboriginal communities in Canada; Part II. Contextual Perspectives on Developmental Risk and WellBeing: 6. Peer victimization: understanding the developmental correlates of at-risk children and youth; 7. The potential risks and adaptive contributions of elite social status to youth development; 8. Culture and context modify neural correlates of adolescent risk-taking behavior; Part III. Contextual Perspectives on Atypicality: 9. Prematurity as a context of development at risk; 10. Maternal depression and children’s behavioral and emotional outcomes: a review of contextual and individual level moderators and mediators; 11. Fragile X-associated disorders: how the family environment and genotype interact; 12. Developmental approaches to understanding and treating autism.

Interdisciplinary Approaches to Knowledge and Development, 39

2014 228 x 152 mm 300pp 17 b/w illus. 5 tables 978-1-107-00885-4 Hardback £65.00 / US$99.00 For all formats available, see

www.cambridge.org/9781107008854

N ew i n Paperbac k

The Psychology of Fatigue Work, Effort and Control Robert Hockey University of Sheffield

The first systematic treatment of fatigue for over sixty years, radically reconfiguring the landscape of the subject. By casting fatigue in the role of an emotion, this book provides a new framework for thinking about it as a mechanism for managing

competing activities and discouraging overcommitment to unrewarding goals.

‘Bob Hockey has produced an outstanding book containing easily the best theoretical account of fatigue ever produced. This book (which also provides a fascinating historical account) is destined to become an ‘instant classic’.’

Michael W. Eysenck, Roehampton University Contents: 1. The problem of fatigue; 2. Changing experiences of fatigue: the social-historical context; 3. The work-fatigue hypothesis; 4. Stress, coping and fatigue; 5. Effort, strain and fatigue; 6. A motivation control theory of fatigue; 7. Extensions and limitations: energy, physical work and sleep; 8. The psychopathology of fatigue; 9. An agenda for fatigue: research and application.

2014 229 x 152 mm 290pp 10 b/w illus. 3 tables 978-1-107-47780-3 Paperback £22.99 / US$36.99 Publication December 2014 Also available 978-0-521-76265-6 Hardback £64.99 / US$104.99 For all formats available, see

www.cambridge.org/9781107477803

Creativity and Mental Illness Edited by James C. Kaufman University of Connecticut

Are creative people more likely to be mentally ill? This book re-examines the common view that a high level of individual creativity often correlates with a heightened risk of mental illness.

Includes contributions from some of the most exciting voices in the fields of psychology, neuroscience, physics, psychiatry, and management.

‘What a joy to see top scholars seriously engage with this controversial topic. This book dispenses with simplistic myths, and stays grounded in scientific research.

The result is a much more complex understanding of the links – and nonlinks – between creativity and mental illness. This book is required reading.’

Keith Sawyer, Morgan Distinguished Professor in Educational Innovations, University of North Carolina, Chapel Hill Contents: Preface; Part I. Creativity and Mental Illness: The State of the Field: 1. A sociohistorical overview of the creativity-pathology connection from antiquity to contemporary times; 2. The mad (creative) genius: what do we know after a century of historiometric research; 3. Reviewing recent empirical findings on creativity and mental illness; 4. Building connections on sand: the cautionary chapter; Part II. Cognitive and Neuroscientific Perspectives on Creativity and Mental Illness: 5. Neurocognitive mechanisms underlying creative thinking: indications from studies of mental illness; 6. The evolutionary genetics of the creativity-psychosis connection; 7. Nonlinearity in creativity and mental illness: the

Related Titles from Cambridge Psychology

mixed blessings of chaos, catastrophe and noise in brain and behavior; 8. Artists’ vulnerability to psychopathology: an integrative cognitive perspective; Part III. Creativity and the Spectrum of Mental Illness: 9. Creativity and the spectrum of affective and schizophrenic psychoses; 10. When good is bad and bad is good: mood, bipolarity, and creativity; 11. Attention-Deficit/ Hyperactivity Disorder (ADHD) and creativity: ever the twain shall meet?; Part IV. Creativity and Mental Illness: Possible Commonalities: 12. The shared vulnerability model of creativity and psychopathology; 13. On the fragility of the artist: art’s precarious triad; 14. Creativity as ‘compensatory advantage’: bipolar and schizophrenic liability, the inverted-u hypothesis, and practical implications; Part V. Creativity and Mental Health: 15. Bringing the whole universe to order: creativity, healing, and post-traumatic growth; 16. Inspiration and the creative process; 17. King Solomon and psychoneuroimmunology: creativity and life coping Part VI. Creativity and Mental Illness: What Now?: 18. Ruminating about mental illness and creativity; 19. Creativity and mental illness: reasons to care and beware.

2014 228 x 152 mm 435pp 5 b/w illus. 4 tables 978-1-107-02169-3 Hardback £70.00 / US$110.00 For all formats available, see

www.cambridge.org/9781107021693

Power, Powerlessness and Addiction Jim Orford University of Birmingham

Jim Orford argues that power and powerlessness have been neglected in addiction studies. He covers the disempowering nature of addiction, effects on family and others, social resources and vulnerability, studies of the legal and illegal supply, and theories of treatment and change.

‘This book brings together Jim Orford’s vast knowledge of addiction research and theory and, using the unifying concept of power, it examines the multi-layered nature of how we are, at several levels, disempowered by our involvement with addictive consumptions. From the three case studies at the opening to his examples of communities reclaiming power at the end, his chapters move progressively from the individual, to families, to neighbourhoods and communities and onto the broader societal and industrial contexts that shape addictions in our lives. It is the first book on addiction I have read that thoroughly integrates so many important strands of thinking on this complex topic.’

Peter J. Adams, Centre for Addiction Research, University of Auckland, and author of Fragmented Intimacy: Addiction in a Social World

Contents: 1. Powerful connections: three examples of addiction; 2. How addiction erodes free agency; 3. Addiction subordinates the interests of family members and friends; 4. Inequality in the power to resist addiction; 5. Power and powerlessness in the addiction supply industries; 6. Reasserting control and power in the process of change and treatment; 7. Facing up to the power of addiction and those who benefit from it.

2013 228 x 152 mm 273pp 978-1-107-61009-5 Paperback £18.99 / US$29.99 For all formats available, see

www.cambridge.org/9781107610095

Synaesthesia and Individual Differences Aleksandra Maria Rogowska Opole University of Technology

Whereas most people understand ‘a warm colour’ as a metaphor, synaesthetes really experience the joining sensations. What is common to all of us and what is unique to synaesthetes? Are we all synaesthetes to some degree? This book explores the relationships between synaesthesia and other dimensions of individual differences.

Contents: Introduction: is synaesthesia normal?; 1. Exploring the structure and distribution of linguistic-colour associations in the concrete-abstract and strong-weak dimensions; 2. Reconciling objective and subjective assessments of linguistic-colour associations: exploring the relationships between linguistic-colour synaesthesia and selfrelated sensing, body lateralization and gender; 3. Cognitive determinants of linguistic-colour associations; 4. Relationships between linguisticcolour synaesthesia and individual differences in absorption, creative thinking, types of mind and intelligence; 5. Exploring the relationships between linguistic-colour associations and selfreported traits of personality and temperament; General conclusions; Appendices.

2015 228 x 152 mm 200pp 36 b/w illus. 8 colour illus. 10 tables 978-1-107-09618-9 Hardback c. £65.00 / c. US$99.00 Publication March 2015 For all formats available, see

www.cambridge.org/9781107096189

Te x t boo k

Child Psychopathology

15

international examples aid student learning.

‘This well-balanced presentation of the empirical science and clinical practice of child psychopathology is much needed. Dr Schneider and colleagues present very readable, seamlessly clear explanations of complex concepts at a sophisticated yet accessible level.

The material is very up-to-date, with balanced, sophisticated coverage of fundamental developmental psychopathological processes. The writing is entertainingly precise, the views refreshingly constructive, and basic concepts are presented in a stimulating and readable way.’

Anna Beth Doyle, Distinguished Professor Emeritus of Psychology, Concordia University, Montréal Contents: Part I. Basic Concepts and Processes: 1. Normality and abnormality in the context of human development: basic definitions; 2. History: from ancient wisdom to the behavioral and cognitive revolutions; 3. Classification of children’s psychological problems: pseudoscience or fundamental part of the helping process?; 4. Genetics and psychopathology; 5. The physiological underpinnings of child psychopathology; 6. Family influences, family consequences and family interventions; 7. The helpful and harmful influences of peers, friends and siblings; 8. Cultural dimensions of child psychopathology; 9. Psychological assessment as part of the caring process; 10. Prevention and mental health promotion; 11. Psychological interventions with children and adolescents: basic concepts; Part II. High-Incidence Disorders: 12. Disruptive behavior disorders; 13. Depression; 14. Attention deficit/hyperactivity disorder; 15. Anxiety disorders; Part III. Developmental Disorders: 16. Intellectual disability; 17. Autism spectrum disorders; 18. Dyslexia and other learning problems as child psychopathology; Part IV. Less Frequent Forms of Child Psychopathology: 19. Eating disorders; 20. Bipolar disorder in childhood and adolescence: a modern-day epidemic?; 21. Substance use disorders; 22. School refusal; 23. Post-traumatic stress disorder; 24. Gender dysphoria in children: or, what is psychopathology?

2014 246 x 189 mm 608pp 56 b/w illus. 13 tables 978-0-521-19377-1 Hardback £70.00 / US$130.00 978-0-521-15211-2 Paperback £37.99 / US$64.99 For all formats available, see

www.cambridge.org/9780521193771

From Infancy to Adolescence Barry H. Schneider University of Ottawa

This undergraduate textbook covers psychopathology from the infant through the adolescent years. Students are led to a rich understanding of the classification, causes, treatment and prevention of psychological disorders in children. The DSM5 and criticisms of it are featured. Case studies and

Social Phobia

An Interpersonal Approach Ariel Stravynski Université de Montréal

Contrary to the received view of social phobia as a disease of abnormal anxiety caused by an inner brain or mind malfunction, this book conceives an alternative approach to social phobia as a defensive and purposeful interpersonal

eBooks available at www.cambridge.org/ebookstore

16

Related Titles from Cambridge Psychology pattern protective against public humiliation or private rejection.

Contents: Part I. The Interpersonal Approach: 1. Social phobia in interpersonal perspective: a conceptual framework and theoretical statement; Part II. What is Social Phobia and What is its Nature?: 2. The received view: social phobia construed as a disorder (disease) of anxiety; 3. The interpersonal outlook: social phobia construed as an extended fearful interpersonal pattern; Part III. What Causes Social Phobia?: 4. Reductive-dualism I: social phobia as a consequence of bodily (brain) defects; 5. Reductive-dualism II: social phobia as a consequence of mental (cognitive) defects; 6. Causality at the interpersonal level: a multicausal analysis; Part IV. Applications of the Interpersonal Approach: 7. Assessment and functional analysis; 8. Treatment: undoing and overhauling social phobia; Part V. Conclusions: 9. Concluding remarks.

2014 228 x 152 mm 339pp 5 b/w illus. 10 tables 978-1-107-00719-2 Hardback £65.00 / US$99.00 For all formats available, see

Printed in the United Kingdom on elemental-chlorine-free paper sourced from responsibly managed forests. 2014

www.cambridge.org/9781107007192

Clinical Perspectives on Autobiographical Memory Edited by Lynn A. Watson Aarhus Universitet, Denmark

and Dorthe Berntsen Aarhus Universitet, Denmark

This collection provides an overview of the mechanisms and characteristics of autobiographical memory, how these are disrupted during psychological disorder and how therapies targeting memory problems can improve well-being. It will be of interest to students of psychology, clinicians and therapists alike.

Advance praise: ‘… the intellectual dialogues in the book not only shed new light on a variety of memory phenomena and psychopathology, but also agree to disagree to the extent where new questions are generated that are likely to move the field forward in the future … an excellent reference book for researchers and students of autobiographical memory and psychopathology.’

Qi Wang, author of The Autobiographical Self in Time and Culture Contents: Introduction: 1. Introduction; Part I. Trauma and Autobiographical Memory: 2. The complex fabric of trauma and autobiographical memory; 3. A basic systems account of trauma memories in PTSD: is more needed?; 4. Construing trauma as a double-edged sword: how narrative components of autobiographical memory

Enhance your brain power

Journals in Mental Health

Find out more at: journals.cambridge.org/psych

relate to devastation and growth from trauma; 5. Child maltreatment and autobiographical memory development: emotion regulation and trauma-related psychopathology; Part II. Intrusive and Involuntary Memories: 6. Intrusive re-experiencing in post-traumatic stress disorder: memory processes and their implications for therapy; 7. Mental imagery in psychopathology: from the lab to the clinic; 8. Intrusive, involuntary memories in depression; 9. From everyday life to trauma: research on everyday involuntary memories advances our understanding of intrusive memories of trauma; Part III. Overgeneral Autobiographical Memories and their Mechanisms: 10. Overgeneral memories and their mechanisms: the relationship with rumination; 11. Overgeneral memory in borderline personality disorder; 12. Difficulties remembering the past and envisioning the future in people with complicated grief and trauma histories; Part IV. Autobiographical Memory, Identity and Psychological Wellbeing: 13. A model of psychopathological distortions of autobiographical memory narratives: an emotion narrative view; 14. Self-images and autobiographical memory in memory impairment; 15. Experimentally examining the role of self-identity in post traumatic stress disorder; 16. The role of self during autobiographical remembering and psychopathology: evidence from philosophical, behavioral, neural and cultural investigations; Part V. Discussion: 17. Autobiographical memory in clinical disorders: a final discussion.

2015 228 x 152 mm 300pp 11 b/w illus. 7 tables 978-1-107-03987-2 Hardback c. £65.00 / c. US$110.00 Publication February 2015 For all formats available, see

www.cambridge.org/9781107039872